Download
Sonderdruck Deutsche medizinische Wochenschrift 5/2015
Diabetes und koronare Herzerkrankung
SD_do_schneider.pdf
Adobe Acrobat Dokument 1.6 MB

Download
Hypoglykämien - Der Diabetologe 2011
s11428-011-0709-9_schneider@pan-klinik d
Adobe Acrobat Dokument 262.1 KB

Literaturverzeichnis Pubmed Prof. Dr. med. C. A. Schneider


Schneider CA, Pfister R.  Herzinsuffizienz und blutzuckersenkende Medikamente. Aktuelle Studienlage und Empfehlungen Diabetes aktuell 2016; 14(7):335-339

O. Schnell, Schneider C. Kardiovaskuläre Sicherheitsstudien 2016: Erwartungen, Überraschungen, Enttäuschungen. Diabetes, Stoffwechsel, Herz 2016; 25: 231-232

Schneider CA. GLP1-Agonist reduziert Mortalität. Diabetes, Stoffwechsle und Herz 2016; 25, August , Klappentext

Bovenschulte H, Schneider C, Prömper CH. Eine einseitige Angelegenheit- Diagnose einer unilobulären linken Lungenatresie beim Erwachsenen mittels MDCT. Fortsch Röntgenstr 2016; 188 ff

Tschöpe C, Kherad B, Spillmann F, Schneider CA, Pieske B, Krackhardt F.  Cardiovascular risk of androgen deprivation therapy for treatment of hormone dependent prostatate cancer: differences between GnRH antagonists and agonists. Herz 2016; April. 15

Pfister R, Ihle P, Mews B, Kohnen E, Wähner M, Höpp H-W, Schneider C.  Migrationsabhängige Akzeptanzbarrieren gegenüber einem strukturierten Versorgungsmodell für Patienten mit chronischer Herzinsuffizienz. Postervortrag  P1824 2.4. 2016; Mannheim, 82. Jahrestagung DGK, Mannheim. 

Schneider CA, Pfister R

Therapie der stabilen Angina pectoris bei Diabetes mellitus Typ 2: Medikamente, Interventionen und Bypass. Deutsche medizinische Wochenschrift 2015; 140:657-662

Haykowsky MJ, Riess KJ, Schneider CA

Ironman triathlon performance pre-and post-heart transplant.

 J Heart Lung Transplant. 2015 May;34(5):756.

Impact factor 5,6.

Schnell O, Tschöpe D, Schneider CA. Editorial . Diabetes Stoffwechsel und Herz 2014; 23: 323

Schneider CA. Die Paradigm Studie- Zeit für einen Paradigmenwechsel in der Therapie der Herzinsuffizienz? Diabetes Stoffwechsel und Herz 2014; 23: 391

Fritz, TPA, Warmbier S, Pfister R, Schneider CA: Prognostische Bedeutung von Diabetes mellitus für Patienten mit symptomatischer Herzinsuffizienz im Rahmen eines kommunalen Versorgungsprojektes. Jahrestagung der Deutschen Gesellschaft für Innere Medizin, Wiesbaden 28.4.2014, P 213

Schneider, CA. Zielwert-orientierte Lipidtherapie- heute und morgen.

Freier Vortrag auf der Jahrestagung der Deutschen Gesellschaft für Innere Medizin 28.4.2014, Wiesbaden

Schneider CA. Lipidtherapie in der Sekundärprävention - Was darf, sollte oder muss man tun?

Jahrestagung der Deutschen Gesellschaft für Kardiologie Mannheim, 25.4.2014 V1470.

Schneider CA. Herausforderung Typ 2 Diabetes: Warum brauchen wir neue Arzneimittel in der Diabetes Therapie? Freier Vortrag auf der Jahrestagung der Deutschen Gesellschaft für Innere Medizin 28.4.2014, Wiesbaden

Schneider CA: Therapie der stabilen KHK bei Patienten mit Typ-2-Diabetes melitus. In: Kursbuch Klinische Diabetologie, Kirchheim Verlag 2013. S. 92-95

Schneider CA. Herzinsuffizienz-häufig übersehen? Das Diagnostik Magazin 2013; 7: 16-20

Warmbier S, Fritz T, Pfister R, Schneider CA. Prognostische Bedeutung des Body-Mass-Index für Patienten mit symptomatischer Herzinsuffizienz im Rahmen eines kommunalen Versorgungsprojektes. Clin Res Cardiol 102; Suppl1, April 2013, P683

Schneider CA. Differentialdiagnose der Luftnot in der Praxis. Das Diagnostik Magazin 2013: 1:4-15.

Schneider CA. The Freedom Study. Diabetes, Stoffwechsel und Herz, 2/2013

Pfister R, Cairns R, Erdmann E, Schneider CA on behalf of the PROactive investigators. A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: An analysis of the PROactive study. Int J Cardiol. 2013 Jan 10;162(2):112-6.

R. Pfister, C. A. Schneider, E. Erdmann. Vorhofflimmern bei Diabetikern mit makrovaskulärer Erkrankung – PROactive-Analyse / Atrial Fibrillation in Diabetic Patients with Macrovascular Disease – PROactive Analysis. Diabetes, Stoffwechsel und Herz 2012:21:221-223

Schmidt A, Jung J, Ernstmann E, Driller E, Neumann M, Staraschek-Jox A, Schneider CA, Wolf J, Pfaff H. The association between active participation in a sports club, physical activity and social network on the development of lung cancer: a case control study. BMC Research Notes 2012,5:2

Anna Schmidt, Elke Driller, Melanie Neumann, Julia Jung, Andrea Staratschek-Jox, Christian Schneider, et al. The association between critical life events, sociodemographic data and physical activity in the development of myocardial infarction in smokers and ex-smokers* Journal of Preventive Medicine 2012; 2: 403-409

Christian Schneider. Kapitel 9: Herz und Kreislauf. In: Praxis der medizinischen Begutachtung. Behinderungen zutreffend einschätzen und begutachten. Hrsg.: P. Nieder, Losch E., Thomann K-D. Referenz Verlag 2012, Frankfurt am Main.

Albus C, Bjarnson-Wehrens B, Gysan DB, Herold G, Schneider CA, Zu Eulenburg C, Predel HG; für die PräFord-Studiengruppe.
The effects of multimodal intervention for the primary prevention of cardiovascular diseases on depression, anxiety, and Type-D pattern : Initial results of the randomized controlled PreFord trial.
Herz 2012 Feb;37(1):59-62 
 
Schneider CA
Verordnungsausschluss von Pioglitazon-Bedeutung für die Praxis und für die Patienten.
Klinikarzt 2011; 6:300
 
Pfister R, Michels G, Cairns R, Schneider CA, Erdmann E.
Incidence of new onset bundle branch block and atrial fibrialltion in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study.

Int J Cardiol. 2011 Dec 1;153(2):233-4. Epub 2011 Oct 9.

 

Schneider CA

Medikamentös induzierte Hypoglykämie bei Typ 2 Diabetes Patienten - Potentieller Auslöser kardiovaskulärer Erkrankungen.

Diabetologe Juni 2011

 

Schneider CA

Diabetes und Herz

Diabetologe Juni 2011

 

Pfister R, Schneider CA 

Diabetes mellitus und Herzinsuffizienz - Duo infernale

Diabetologe Juni 2011

 

Pfister R, Cairns R, Erdmann E, Schneider CA.

Prognostic impact of electrocardiographic signs in patients with Type2 diabetes and cardiovascular disease: results from the PROactive study.

Diabet Med. 2011  

  

Pfister R, Erdmann E, Schneider CA.

Association and prognostic impact of heart rate and micro- albuminuria in patients with type 2 diabetes and cardiovascular disease: results from the PROactive trial.

J Atheroscler Thromb. 2011 Jan 27;18(1):65-71. Epub 2010 Nov 13.

 

Pfister R, Hagemeister J, Esser S, Hellmich M ,Erdmann  E, Schneider CA. NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized

for syncope. Int. J. Cardiol Okt 2010

 

Schneider CA, Pfister R, Erdmann E. Diabetes und Herzinsuffizienz. [Diabetes and heart failure]. Herz. 2010 May;35(3):140-6. German.


Pfister R, Müller-Ehmsen J, Hagemeister J, Hellmich M, Erdmann E, Schneider
CA. NT-pro-BNP predicts worsening renal function in patients with chronic
systolic heart failure (NT-pro-BNP and renal function). Intern Med J. 2010 Feb
26. [Epub ahead of print] PubMed PMID: 20214692.


Diedrichs H, Pfister R, Clement Z, Hagemeister J, Schneider CA. Delta-glycated
hemoglobin: a novel independent risk factor for cardiovascular events in patients
without diabetes mellitus. J Endocrinol Invest. 2009 Jul;32(7):564-7. Epub 2009
Jun 15. PubMed PMID: 19535894.


Pfister R, Strack N, Wielckens K, Malchau G, Erdmann E, Schneider CA. The
relationship and prognostic impact of low-T3 syndrome and NT-pro-BNP in
cardiovascular patients. Int J Cardiol. 2009 May 6. [Epub ahead of print] PubMed
PMID: 19423177.


Pfister R, Schneider CA. ESC guidelines for the diagnosis and treatment of
acute and chronic heart failure 2008: application of natriuretic peptides. Eur
Heart J. 2009 Feb;30(3):382-3; author reply 383. Epub 2008 Dec 24. PubMed PMID:
19109350.


Hagemeister J, Schneider CA, Diedrichs H, Mebus D, Pfaff H, Wassmer G, Höpp
HW. Inefficacy of different strategies to improve guideline awareness - 5-year
follow-up of the hypertension evaluation project (HEP). Trials. 2008 Jun 25;9:39.
PubMed PMID: 18578855; PubMed Central PMCID: PMC2443109.


Pfister R, Diedrichs H, Dietlein M, Erdmann E, Schneider CA. Typical and
atypical takotsubo-like cardiomyopathy as a manifestation of pheochromocytoma. J
Endocrinol Invest. 2008 Apr;31(4):382-3. PubMed PMID: 18475060.


Pfister R, Tan D, Thekkanal J, Erdmann E, Schneider CA. [Predictive value of
NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with
cardiovascular disease]. Dtsch Med Wochenschr. 2008 Mar;133(12):564-9. German.
PubMed PMID: 18335382.


Pfister R, Diedrichs H, Schiedermair A, Rosenkranz S, Hellmich M, Erdmann E,
Schneider CA. Prognostic impact of NT-proBNP and renal function in comparison to
contemporary multi-marker risk scores in heart failure patients. Eur J Heart
Fail. 2008 Mar;10(3):315-20. Epub 2008 Mar 4. PubMed PMID: 18304872.


Pfister R, Diedrichs H, Larbig R, Erdmann E, Schneider CA. NT-pro-BNP for
differential diagnosis in patients with syncope. Int J Cardiol. 2009 Mar
20;133(1):51-4. Epub 2008 Jan 30. PubMed PMID: 18237792.


Diedrichs H, Frank K, Schneider CA, Burst V, Hagemeister J, Zobel C,
Müller-Ehmsen J. Increased functional importance of the Na,Ca-exchanger in
contracting failing human myocardium but unchanged activity in isolated vesicles.
Int Heart J. 2007 Nov;48(6):755-66. PubMed PMID: 18160767.


Schneider CA, Ferrannini E, Defronzo R, Schernthaner G, Yates J, Erdmann E.
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney
disease. J Am Soc Nephrol. 2008 Jan;19(1):182-7. Epub 2007 Dec 5. PubMed PMID:
18057215; PubMed Central PMCID: PMC2391042.


Diedrichs H, Hagemeister J, Chi M, Boelck B, Müller-Ehmsen J, Schneider CA.
Activation of the calcineurin/NFAT signalling cascade starts early in human
hypertrophic myocardium. J Int Med Res. 2007 Nov-Dec;35(6):803-18. PubMed PMID:
18034994.


Diedrichs H, Pfister R, Hagemeister J, Müller-Ehmsen J, Frank KF, Höpp HW,
Erdmann E, Schneider CA. An increase in HbA1c after percutaneous coronary
intervention raises the risk for restenosis in patients without Type 2 diabetes
mellitus. Diabet Med. 2008 Feb;25(2):228-31. Epub 2007 Nov 19. PubMed PMID:
18028437.


Pfister R, Tan D, Thekkanal J, Hellmich M, Schneider CA. Predictors of
elevated NT-pro-BNP in cardiovascular patients without acute heart failure. Int J
Cardiol. 2009 Jan 9;131(2):277-80. Epub 2007 Oct 25. PubMed PMID: 17913264.


Schneider CA, Erdmann E. [Stable angina pectoris can be treated successfully
by drugs alone--pro]. Dtsch Med Wochenschr. 2007 Sep;132(39):2024. German. PubMed
PMID: 17882742.


Pfister R, Tan D, Thekkanal J, Hellmich M, Erdmann E, Schneider CA.
NT-pro-BNP measured at discharge predicts outcome in multimorbid diabetic
inpatients with a broad spectrum of cardiovascular disease. Acta Diabetol. 2007
Jun;44(2):91-7. Epub 2007 May 27. PubMed PMID: 17530473.


Schneider CA, Herold G, Gysan D, Albus C, Bjarnason-Wehrens B, Predel HG.
Prevalence of cardiovascular risk factors in middle-aged type 2 diabetic
automobile employees assessed at the workplace--the Praeford study. J Occup
Environ Med. 2007 May;49(5):481-3. PubMed PMID: 17495690.


Pfister R, Tan D, Thekkanal J, Hellmich M, Schneider CA. NT-pro-BNP is
associated with long-term outcome in a heterogeneous sample of cardiac
inpatients. Eur J Intern Med. 2007 May;18(3):215-20. PubMed PMID: 17449394.


Pfützner A, Schneider CA, Forst T. Pioglitazone: an antidiabetic drug with
cardiovascular therapeutic effects. Expert Rev Cardiovasc Ther. 2006
Jul;4(4):445-59. Review. PubMed PMID: 16918264.


Schneider CA. Improving macrovascular outcomes in type 2 diabetes: Outcome
studies in cardiovascular risk and metabolic control. Curr Med Res Opin. 2006;22
Suppl 2:S15-26. Review. PubMed PMID: 16914072.


Zobel C, Kuhn-Regnier F, Krüger K, Gerharz M, Schneider CA, Müller-Ehmsen J,
Erdmann E. Echinococcus cyst located in the interventricular septum. Clin Res
Cardiol. 2006 Nov;95(11):600-4. Epub 2006 Aug 16. PubMed PMID: 16897142.


Schneider CA. [Percutaneous closure of patent foramen ovale-- Against]. Dtsch
Med Wochenschr. 2006 Apr 7;131(14):771. German. PubMed PMID: 16596498.


Schneider CA, Gallwitz B, Hanefeld M, Leschke M, Müller-Wieland D, Zeymer U,
Erdmann E. [Hyperglycemia and cardiovascular events]. Dtsch Med Wochenschr. 2004
Nov 19;129(47):2553-7. Review. German. PubMed PMID: 15543474.


Pfister R, Schneider CA. Natriuretic peptides BNP and NT-pro-BNP: established
laboratory markers in clinical practice or just perspectives? Clin Chim Acta.
2004 Nov;349(1-2):25-38. Review. PubMed PMID: 15469852.


Schneider CA, Erdmann E. [Secondary prevention of cardiovascular diseases].
Internist (Berl). 2004 Jun;45 Suppl 1:S23-30. German. PubMed PMID: 15148584.

 

Schmidt M, Voth E, Schneider CA, Theissen P, Wagner R, Baer FM, Schicha H.
F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but
viable infarct regions as defined by magnetic resonance imaging before and after
revascularization. Magn Reson Imaging. 2004 Feb;22(2):229-36. PubMed PMID:
15010115.


Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Use of NT-proBNP
in routine testing and comparison to BNP. Eur J Heart Fail. 2004 Mar
15;6(3):289-93. PubMed PMID: 14987578.


Gysan DB, Latsch J, Bjarnason-Wehrens B, Albus C, Falkowski G, Herold G, Mey
E, Heinzler R, Montiel G, Schneider CA, Stützer H, Türk S, Weisbrod M, Predel HG.
[The PreFord Study. A prospective cohort study to evaluate the risk of a
cardiovascular event (overall-collective) as well as a prospective, randomized,
controlled, multicentre clinical intervention study (high-risk-collective) on
primary prevention of cardiovascular diseases in the Ford Motor Company employees
in Germany]. Z Kardiol. 2004 Feb;93(2):131-6. German. PubMed PMID: 14963679.


Schneider CA. [Is "COMET" pointing in the right direction?--Con]. Dtsch Med
Wochenschr. 2003 Dec 12;128(50):2667. German. PubMed PMID: 14673748.


Schneider CA. [Diagnosis of ischemia--adequate clinical and exercise-ECG for
indicating the need for cardiac catheterization?--Contra]. Dtsch Med Wochenschr.
2003 Oct 10;128(41):2154-5. German. PubMed PMID: 14534866.


Hagemeister J, Schneider CA, Schönegge N, Leskaroski A, Pfaff H, Höpp HW.
[Physicians and the internet--a cross-sectional study against the background of
guideline implementation]. Z Arztl Fortbild Qualitatssich. 2003;97(6):407-13.
German. PubMed PMID: 14524056.


Pfister R, Erdmann E, Schneider CA. [Natriuretic peptides BNP and
NT-pro-BNP--the "new troponins" for estimation of heart failure?]. Dtsch Med
Wochenschr. 2003 May 2;128(18):1007-12. Review. German. PubMed PMID: 12721882.


Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. [The value of
natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular
volume and function. A prospective study of 150 patients]. Dtsch Med Wochenschr.
2002 Dec 6;127(49):2605-9. German. PubMed PMID: 12469271.


Schneider CA. [How is antianginal therapy with pentaerythritol tetranitrate
executed?]. Dtsch Med Wochenschr. 2002 Nov 15;127(46):2465. German. PubMed PMID:
12432490.


Schmidt M, Jochims M, Theissen P, Baer FM, Crnac J, Voth E, Schneider CA,
Erdmann E, Schicha H. [Comparison of dobutamine-stress magnetic resonance imaging
and dipyridamole-TL-201-SPECT as alternative strategies for the detection of
coronary artery dis in patients no suitable for stress echocardiography].
Nuklearmedizin. 2001 Dec;40(6):198-206. German. PubMed PMID: 11797508.


Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G, Pfaff
H, Höpp HW. Hypertension guidelines and their limitations--the impact of
physicians' compliance as evaluated by guideline awareness. J Hypertens. 2001
Nov;19(11):2079-86. PubMed PMID: 11677375.


Schneider CA, Hagemeister J, Pfaff H, Mager G, Höpp HW. [Guideline-adequate
knowledge in internists and general practitioners about the diagnosis and
treatment of arterial hypertension]. Z Arztl Fortbild Qualitatssich. 2001
Jun;95(5):339-44. German. PubMed PMID: 11486497.


Moka D, Baer FM, Theissen P, Schneider CA, Dietlein M, Erdmann E, Schicha H.
Non-Q-wave myocardial infarction: impaired myocardial energy metabolism in
regions with reduced 99mTc-MIBI accumulation. Eur J Nucl Med. 2001
May;28(5):602-7. PubMed PMID: 11383865.


Schneider CA, Erdmann E. [Coronary bypass surgery in obese patients?]. Dtsch
Med Wochenschr. 2001 Apr 12;126(15):418. German. PubMed PMID: 11347002.


Schneider CA, Diedrichs H, Riedel KD, Zimmermann T, Höpp HW. In vivo uptake
of azithromycin in human coronary plaques. Am J Cardiol. 2000 Oct 1;86(7):789-91,
A9. PubMed PMID: 11018204.


Schneider CA, Voth E, Moka D, Wagner R, Schicha H, Erdmann E, Baer FM.
[Dobutamine-induced changes in the myocardial blood flow in patients with
coronary heart diseases. A quantitative analysis using [15O] H2O positron
emission tomography]. Dtsch Med Wochenschr. 2000 Apr 28;125(17):512-6. German.
PubMed PMID: 10829794.


Sechtem U, Baer FM, Voth E, Theissen P, Schneider CA. Stress functional MRI:
detection of ischemic heart disease and myocardial viability. J Magn Reson
Imaging. 1999 Nov;10(5):667-75. Review. PubMed PMID: 10548774.


Hoepp HW, Deutsch HJ, La Rosée K, Schnabel P, Terheggen G, Schneider CA,
Korsten J, Babic UU. Transcatheter closure of atrial-septal defects and patent
foramen ovale in adults: optimal anatomic adaptation of occlusion device. Am
Heart J. 1999 Nov;138(5 Pt 1):941-9. PubMed PMID: 10539827.


Schneider CA, Voth E, Moka D, Baer FM, Melin J, Bol A, Wagner R, Schicha H,
Erdmann E, Sechtem U. Improvement of myocardial blood flow to ischemic regions by
angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O]
water dobutamine stress positron emission tomography. J Am Coll Cardiol. 1999
Oct;34(4):1005-11. PubMed PMID: 10520782.


La Rosée K, Deutsch HJ, Schnabel P, Schneider CA, Burkhard-Meier C, Höpp HW.
Thrombus formation after transcatheter closure of atrial septal defect. Am J
Cardiol. 1999 Aug 1;84(3):356-9, A9. PubMed PMID: 10496455.


Baer FM, Theissen P, Schneider CA, Kettering K, Voth E, Sechtem U, Schicha H.
MRI assessment of myocardial viability: comparison with other imaging techniques.
Rays. 1999 Jan-Mar;24(1):96-108. Review. English, Italian. PubMed PMID: 10358387.


Schneider CA, Baer FM, Erdmann E. [QT-dispersion--analysis and prognostic
implications]. Dtsch Med Wochenschr. 1999 Apr 1;124(13):396-402. Review. German.
PubMed PMID: 10226648.


Schneider CA, Voth E, Gawlich S, Baer FM, Horst M, Schicha H, Erdmann E,
Sechtem U. Significance of rest technetium-99m sestamibi imaging for the
prediction of improvement of left ventricular dysfunction after Q wave myocardial
infarction: importance of infarct location adjusted thresholds. J Am Coll
Cardiol. 1998 Sep;32(3):648-54. PubMed PMID: 9741506.


Schneider CA, Helmig AK, Baer FM, Horst M, Erdmann E, Sechtem U. Significance
of exercise-induced ST-segment elevation and T-wave pseudonormalization for
improvement of function in healed Q-wave myocardial infarction. Am J Cardiol.
1998 Jul 15;82(2):148-53. PubMed PMID: 9678283.


Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H, Erdmann E.
Dobutamine magnetic resonance imaging predicts contractile recovery of
chronically dysfunctional myocardium after successful revascularization. J Am
Coll Cardiol. 1998 Apr;31(5):1040-8. PubMed PMID: 9562005.


Schneider CA, Voth E, Baer FM, Horst M, Wagner R, Sechtem U. QT dispersion is
determined by the extent of viable myocardium in patients with chronic Q-wave
myocardial infarction. Circulation. 1997 Dec 2;96(11):3913-20. PubMed PMID:
9403615.


Baer FM, Voth E, LaRosée K, Schneider CA, Theissen P, Deutsch HJ, Schicha H,
Erdmann E, Sechtem U. Comparison of dobutamine transesophageal echocardiography
and dobutamine magnetic resonance imaging for detection of residual myocardial
viability. Am J Cardiol. 1996 Aug 15;78(4):415-9. PubMed PMID: 8752185.


Baer FM, Voth E, Deutsch HJ, Schneider CA, Horst M, de Vivie ER, Schicha H,
Erdmann E, Sechtem U. Predictive value of low dose dobutamine transesophageal
echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography
for recovery of regional left ventricular function after successful
revascularization. J Am Coll Cardiol. 1996 Jul;28(1):60-9. PubMed PMID: 8752795.


Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Comparison
of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron
emission tomography with [18F]fluorodeoxyglucose in patients with chronic
coronary artery disease. A functional and morphological approach to the detection
of residual myocardial viability. Circulation. 1995 Feb 15;91(4):1006-15. PubMed
PMID: 7850935.


Baer FM, Voth E, Theissen P, Schneider CA, Schicha H, Sechtem U. Coronary
artery disease: findings with GRE MR imaging and
Tc-99m-methoxyisobutyl-isonitrile SPECT during simultaneous dobutamine stress.
Radiology. 1994 Oct;193(1):203-9. PubMed PMID: 8090892.


Baer FM, Theissen P, Voth E, Schneider CA, Schicha H, Sechtem U. Morphologic
correlate of pathologic Q waves as assessed by gradient-echo magnetic resonance
imaging. Am J Cardiol. 1994 Sep 1;74(5):430-4. PubMed PMID: 8059720.


Baer FM, Voth E, Deutsch HJ, Schneider CA, Schicha H, Sechtem U. Assessment
of viable myocardium by dobutamine transesophageal echocardiography and
comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J Am
Coll Cardiol. 1994 Aug;24(2):343-53. PubMed PMID: 8034866.


Voth E, Baer FM, Theissen P, Schneider CA, Sechtem U, Schicha H. Dobutamine
99mTc-MIBI single-photon emission tomography: non-exercise-dependent detection of
haemodynamically significant coronary artery stenoses. Eur J Nucl Med. 1994
Jun;21(6):537-44. PubMed PMID: 8082670.


Schneider CA, Voth E, Theissen P, Wienhard K, Wagner R, Baer FM, Sechtem U,
Schicha H. [Assessing myocardial viability in chronic myocardial infarct with
18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT]. Z
Kardiol. 1994 Feb;83(2):124-31. German. PubMed PMID: 8165842.


Baer FM, Theissen P, Schneider CA, Voth E, Schicha H, Sechtem U. [Magnetic
resonance tomography imaging techniques for diagnosing myocardial vitality].
Herz. 1994 Feb;19(1):51-64. Review. German. PubMed PMID: 8150414.


Schneider CA, Taegtmeyer H. Fasting in vivo delays myocardial cell damage

after brief periods of ischemia in the isolated working rat heart. Circ Res. 1991
Apr;68(4):1045-50. PubMed PMID: 2009607.


Schneider CA, Nguyêñ VT, Taegtmeyer H. Feeding and fasting determine
postischemic glucose utilization in isolated working rat hearts. Am J Physiol.
1991 Feb;260(2 Pt 2):H542-8. PubMed PMID: 1996697.